Birdwatch Note Rating
2023-03-16 19:08:44 UTC - HELPFUL
Rated by Participant: B97A7A89B56B9AAABB515A33D72104DAE2CABC42DC350C82FAB8E5474078965F
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details